CBU
DXCM icon

CIBC Bancorp USA’s DexCom DXCM Stock Holding History

CIBC Bancorp USA’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233M Sell
3,454,735
-762,399
-18% -$50.8M 0.28% 85
2026
Q1 		$265M Buy
+4,217,134
New +$294M 0.36% 66
2025
Q3 		$4.61M Buy
+68,460
New +$5.42M 0.03% 416

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CIBC Bancorp USA's DXCM Position: Q2 2026 in Review

CIBC Bancorp USA reduced its DexCom (DXCM) stake by 18% in Q2 2026, selling an estimated $50.8M and leaving 3,454,735 shares worth $233M. The position accounts for 0.28% of the portfolio, ranked #85.

CIBC Bancorp USA first reported a position in DXCM in Q3 2025 and has held it in 3 quarters since. The position peaked at $265M in Q1 2026. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • CIBC Bancorp USA held 3,454,735 shares of DexCom worth $233M as of Q2 2026.
  • CIBC Bancorp USA sold 762,399 DexCom shares in Q2 2026, an estimated $50.8M.
  • DexCom made up 0.28% of CIBC Bancorp USA's portfolio in Q2 2026, its #85 holding.
  • CIBC Bancorp USA first reported a position in DexCom in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's DexCom position peaked at $265M in Q1 2026.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.